Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohortNuno Jorge Lamas, Paul Hofman, Olivier Bordone et al.|Pathology|2023Cited by 10